Moreover, treatment with a compound (Genz-123346) that inhibits glycosphingolipid biosynthesis decreases mTOR activity and restores TFEB expression in GBA-PD iPSC neurons, demonstrating a possible link between mTOR-TFEB alterations and lipid accumulation [68]. Here, TFEB is linked to Parkinson disease.